|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety and immuno- genicity of Env2-3, a human immunodeficiency virus type I candi- date vaccine, in combination with a novel adjuvant, MTP- PE/ MF59显示文摘 | Keefer MC Graham BS McElrath M J | 1996 | AIDS Res Hum Retroviruses1996，12，8： | 1 |
| 2 | Phase 2 study of an HIV-1 canarypox vaccine (vCPI452) alone and in combination with rgpl20: negative results fail to trigger a phase 3 correlates trial 显示文摘 | Russell ND Graham BS Keefer MC | 2007 | J Acquir Immune Defic Syndr2007，44，2： | 1 |
| 3 | Safety and immunogencity of Env 2-3,a human immunodeficiency virus type 1 candidate vaccine,in combination with a novel adjuvant,MTPPE/MF59显示文摘 | Keefer MC Wolff M Gorse GJ | 1997 | AIDS Res Hum Retroviruses1997，13，： | 1 |
| 4 | A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgpl20 elicits broad and durable CD8+cytotoxic T lymphocyte responses in seronegative volunteers显示文摘 | EVANS TG KEEFER MC WEINHOLD KJ | 1999 | Infect Dis1999，280，： | 1 |
| 5 | Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial显示文摘 | Russell ND Graham BS Keefer MC | 2007 | J Acquir Immune Defic Syndr2007，44，2： | 1 |
| 6 | A canarypox vaccine expressing mulyiple human immunodeficiency virus type 1 genes given alone or with gp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seroneg-ative volunteers显示文摘 | EVANS TG KEEFER MC WEINHOLD KJ | 1999 | J Infect Dis1999，180，2： | 1 |
| 7 | Safety and immunogencity of Env 2-3,a human immunodeficiency virus type 1 candidate vaccine,in combination with a novel adjuvant,MT-PPE/MF59显示文摘 | Keefer MC Wolff M Gorse GJ | 1997 | AIDS Res Hum Retroviruses1997，13，14： | 1 |
| 8 | Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens 显示文摘 | Asmuth DM Brown EL DiNubile MJ Sun X del Rio C Harro C Keefer MC Kublin JG Dubey SA Kierstead LS Casimiro DR Shiver JW Robertson MN Quirk EK Me- hrotra DV | 2010 | J In- fect Dis2010，201，1： | 1 |
| 9 | Safety and immunogenicity of Env2-3,a human immunodeficiency virus type I candidate vaccine,in combination with PPE/MF59显示文摘 | Keefer MC Wolff M Gorse GJ | 1997 | AIDS Res Hum Retroviruses1997，13，14： | 1 |
| 10 | HSV-1 amplicon vec-tors elicit polyfunctional T cell responses to HIV-1 Env,andstrongly boost responses to an adenovirus prime显示文摘 | Duke CM Maguire CA Keefer MC | 2007 | Vaccine2007，25，42： | 1 |
| 11 | Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120:negative results fail to trigger a phase 3 correlates trial显示文摘 | Russell ND Graham BS Keefer MC | 2007 | J Acquir Immune Defic Syndr2007，44，2： | 1 |
| 12 | Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A显示文摘 | Reuman PD Bernstein DI Keefer MC | 1989 | Antiviral Res1989，1，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员